Abstract
Background
Worldwide, L. pneumophila sg 1 is the most common agent of Legionnaires’ disease ( 80 to 90% of the reported cases). In contrast, L. pneumophila sg 2–14 account for only 15 to 20% of community-acquired cases, although they account for over 50% of the environmental isolates. The discrepancy between environmental isolates and clinical cases of disease suggested that there are differences in virulence.
We decided to subtype the environmental Legionella strains isolated from health care facilities (HCFs) and to compare the distribution of strains with the occurrence of hospital-acquired legionellosis.
Methods
Observational ecological study based on the data provided by the regional surveillance of legionellosis and on data obtained from hospitals environmental monitoring.
Using the monoclonal antibody MAb 3/1 of the Dresden Panel we collected and typed environmental strains of L. pneumophila sg 1 obtained during routine testing in 56 health care facilities from 2004 to 2009.
The results of the laboratory analyses of the environmental samples were compared with the number of cases that each health care facility reported during the study period.
Results
The association between the type of colonisation (L. pneumophila sg 1 vs others serogroups) and the incidence of reported cases was statistically significant (p = 0.03 according to the χ2 test).
Legionella strains with the virulence–associated epitope recognised by MAb 3/1 were isolated in 8 of the 26 HCFs colonised by L. pneumophila sg 1; 7 of the HCFs colonised by MAb 3/1-positive strains accounted for 85% of the cases of hospital-acquired legionellosis reported during the 6-year study period. There was a statistically significant association (p = 0.003) between the presence of cases and colonisation by MAb 3/1-positive Legionella strains.
Conclusion
This study suggests that hospitals colonised by more virulent strains should be aware of the increased risk and consider the opportunities of increase their monitoring efforts and implement more effective contamination control strategies.
Background
Hospital water systems have been identified as a source of Legionella pneumonia. Legionella pneumophila serogroup 1 is the most common cause of legionellosis, a sporadic and endemic disease that may be acquired from different environmental sources [1].
The utility of environmental monitoring for Legionella species remains controversial.
Two different strategies for preventing hospital-acquired Legionella pneumonia have been advocated. One strategy emphasises environmental monitoring for Legionella species [2], and because the contamination of a hospital’s water supply by Legionella species can place inpatients at risk of developing hospital-acquired Legionella pneumonia, this strategy encourages pneumonia surveillance through diagnostic testing. An alternative strategy proposed by the United States Centers for Disease Control and Prevention [3] advocates intensive clinical surveillance without routine environmental surveillance, except in transplant units [4]. National and international guidelines for Legionella prevention and control set risk and intervention threshold levels for water distribution systems based on the Legionella load detected in samples. Currently, the French guidelines [5] are alone in recommending that risk levels be graded according to the quantity of microorganisms plus the Legionella species and serogroups present in a hospital’s water supply. Previously, we reported [6] the findings of a two-year prospective study on the incidence of nosocomial legionellosis in hospitals contaminated with L. pneumophila other than serogroup 1 or non-Legionella pneumophila species. In the hospitals that only performed regular ordinary maintenance without carrying out decontamination measures, the results (32 hospitals, 325,703 patients, only one case of healthcare-associated Legionnaires’ disease reported) confirm that the presence of Legionella in a hospital’s water distribution system does not necessarily lead to legionellosis [7, 8], and in hospitals contaminated with L. pneumophila non-sg 1, the risk of developing legionellosis is very low.
Worldwide, L. pneumophila sg 1 is the most common agent of Legionnaires’ disease, accounting for approximately 80 to 90% of the reported cases [9–11] and approximately 70% of European travel-associated cases [12]. In contrast, L. pneumophila sg 2–14 account for only 15 to 20% of community-acquired cases, although they account for over 50% of the isolates obtained from man-made aquatic systems. The discrepancy between environmental isolates and clinical cases of disease has been observed by Doleans et al. [13], who suggested that there are differences in virulence rather than greater abundance in water distribution systems. This discrepancy was also reported by Harrison et al. [14], who found a higher proportion of only a few restriction-fragment-length polymorphism (RFLP) types in clinical isolates compared with the more even distribution of RFLP types seen in environmental isolates.
In Italy, legionellosis is subject to special surveillance [15]. Physicians who diagnose legionellosis cases, whether they are hospital or community acquired, notify the local health authority via normal reporting channels. This information is then sent to the regional authorities (Regional Epidemiological Services for the Monitoring, Prevention and Control of Infectious Diseases [SeREMI), which then forward the information to the Ministry of Health, the Italian National Institute of Statistics (ISTAT) and the Istituto Superiore di Sanità (ISS). In the last 10 years, 164 hospital-acquired legionellosis cases occurring in Piemonte have been reported through this surveillance network; 112 of these cases were reported at two of the region’s major hospitals. This marked difference in the attack rates suggests that the L. pneumophila sg 1 strains in some hospitals may be more pathogenic than those circulating in hospitals where no cases of legionellosis have been reported. Therefore, we decided to subtype the Legionella strains isolated during environmental monitoring with monoclonal antibody MAb 3/1 of the Dresden Panel (corresponding to MAb 2 of the International Panel) directed against lipopolysaccharide epitopes on the surface of Legionella cells [16, 17]. According to epidemiological studies, this epitope appears to be associated with virulence [18, 19]. One possible explanation for the higher virulence potential of strains carrying the epitope recognised by MAb 3/1 is that legionellae are more likely to survive in aerosols, increasing the dose inhaled by exposed individuals. Immunochemical analysis of the epitope has suggested that the increased hydrophobicity of these strains encourages the survival of these legionellae in aerosols [20]. Gosselin et al. [21] studied the electrokinetic patterns of strains carrying the MAb3/1 epitope and provided a physicochemical explanation for the role played by the MAb3/1 epitope in Legionella cases. They demonstrated that virulent MAb3/1-positive strains have an average flow penetration length (1/λ0) that is 1.5 times larger and a volume charge density (ρ0) that is approximately 5 times lower than those derived from less virulent MAb3/1-negative strains.
The infection potential of Legionella pneumophila sg1 strains is most pronounced for bacteria with a low ρ0 and a large λ0 that carry the MAb3/1 epitope. The larger ρ0 is the more important the repulsion between Legionella pneumophila sg1 and host cell is, and the lower is the probability of these cells to be infected.
The purpose of this study was to compare the distribution of L. pneumophila sg 1 monoclonal subtypes obtained during routine sampling in HCFs water systems with the distribution of hospital-acquired legionellosis, to assess the risk associated with contaminated environmental reservoirs colonised by more virulent strains.
Methods
Study design
This is an observational ecological study based on the data provided by the regional surveillance of legionellosis and on data obtained from hospitals environmental monitoring of Legionella.
The number of cases that each health care facility reported was compared to the environmental strains of Legionella (detected, enumerated and serotyped).
Health care facilities (HCFs)
Altogether 56 HCFs were monitored, 46 were hospitals and 10 long term care facilities(LTCF).
The hospitals varied in size: 1250 beds (one hospital), 500–1000 beds (3 hospitals), 200–500 beds (15 hospitals) and <200 beds (27 hospitals). The mean age of the buildings was 40 years, but over the years, the water systems had been partially renovated.
Over the years, we have gained a fairly complete picture of the situation at 56 health care facilities (HCFs), contaminated with Legionella, that implement routine testing and management interventions. Until 2008, the majority of HCFs carried out regular controls twice a year (on a total of 20 samples per year). Since April of 2008, the Piemonte region authorities [22, 23] have invited HCF to implement environmental monitoring programmes that require quarterly sampling of their water supply and recirculation loops of boilers; this regime identifies fluctuations in the colonisation of Legionella. Sampling at distal sites is limited to the facilities where patients at high risk of infection are hospitalised. In addition to environmental monitoring, the Piemonte Regional authorities advocate clinical surveillance performed by the Infection Control Committee, emphasising that physicians should require Legionella diagnostic tests for patients with pneumonia.
In the first few years of environmental monitoring, all the hospitals proved to be contaminated by Legionella spp., although marked differences were seen in terms of microbial load and types of strains; the most frequently isolated strains were L. pneumophila serogroups 1, 3, 6. The age and size of the buildings were not associated with the degree of contamination. The massive contamination found during the first years of monitoring gradually diminished as a result of remedial intervention on the water systems monitored [24].
The hospitals were classified according to the Case-Mix Index (CMI), which was obtained from the Regional Department of Health (RDH). To calculate the CMI, RDH used the Medicare Severity-Diagnosis Related Group (MS-DRG) weights by averaging the MS-DRG weight of all patients discharged within the calendar. CMI describes the complexity of cases managed by every hospital in relation to the average complexity of Italian hospitals. In this study we used CMI as a confounding variable and considered the hospitals with a CMI greater than 1 as facilities with case - complexity higher than reference, as defined by the Ministry of health.
Long-term care facilities (LTCFs) are establishments where non-self-sufficient patients who cannot be assisted at home and can be accommodated for an indefinite period of time. The majority of patients in these establishments are elderly, with chronic morbidities and often confined to bed, conditions that are important risk factors for infection with Legionella spp. The sizes of these establishments varied from 30 beds to 177 beds. For the LTCF the case-mix index was not provided, so we arbitrarily assigned a value index < 1.
Diagnosis of Legionellosis
Hospitals performed active surveillance for Legionella infection for all cases of nosocomial pneumonia identified by clinical, radiological, and laboratory criteria according to national and international case definition [3, 15].
In our setting, if a patient had pneumonia urine specimens were collected and examined for Legionella antigen; if the results were negative, the test was repeated 5–7 days later. Culture of respiratory secretions when possible was recommended, as was testing for specific antibodies on the onset of symptoms and after 15–20 days. Urinary antigen detection is sufficient to start a therapy and initiate an environmental investigation. The discovery of Legionella in the water supply led to initiate the disinfection of the plumbing system.
The following definition integrate the clinical and microbiological criteria that classify a patient as a nosocomial case of Legionnaires’ disease and is used for surveillance purposes:
“definite nosocomial” case of Legionnaires’ disease who was in a hospital or nursing home or other healthcare facility for at least ten days prior to the onset of symptoms.
The management of active surveillance was assigned to the hospital’s Infection Control Committee that, in collaboration with the infection control nurse, collected data about patients with nosocomial pneumonia and reported this information to the regional surveillance network (SeREMI). During the study period (2004–2009) this network had reported cases of hospital-acquired legionellosis that were detected by positive urine antigen tests; in any cases was available culture of respiratory secretions and species/serogroup information.
This study did not require ethical approval, we only accessed the number of cases that each health care facility referred to SeREMI and analyzed virulence only on environmental samples.
Environmental isolates
We collected data (about 5600 water samples) and environmental strains obtained from routine testing conducted in 56 HCFs from 2004 to 2009. The water-testing data and environmental strains for 15 hospitals were furnished by the Regional Agency for Environmental Protection (ARPA Piemonte).
Legionella spp. were isolated using a cultural method according to the ISO 11731 standard technique [25].
Using MAbs 3/1, we typed the 264 environmental strains collected from the HCFs water supply colonised by L. pneumophila sg 1. We tested more than one strain from different years at each HCF to identify possible variations in the reactivity of MAb3/1, as suggested by Bernarder et al. [26].
Monoclonal Subgrouping of isolates
The L. pneumophila sg 1 strains were classified according to whether they expressed the virulence-associated epitope (MAb 3/1-positive) or not (MAb 3/1-negative). The L. pneumophila sg 1 strains were typed with MAbs 3/1 of the Dresden panel using an indirect immunofluorescence test (IIFT) [16, 17]. Legionella bacteria were scraped from BCYE agar, fixed for 10 min in acetone, resuspended in distilled water to a concentration of approximately 3x108 and subjected to indirect immunofluorescence testing [27]. The MAb 3/1 were used as undiluted cell culture supernatants, and goat antimouse fluorescein isothiocyanate conjugate (polyvalent) (Sigma Aldrich, St Louis, USA) was used after being diluted 1:64.
Statistical analysis
The χ2 test, Fisher’s exact test and stratification by CMI were applied to determine whether there was an association between legionellosis cases and the type of colonisation in the health care facility’s water supply system. For data processing the case-mix index were grouped into two categories: hospitals with CMI < 1 and hospitals with CMI > 1.
Results
Table 1 shows the main information (CMI, bed-sites, number of nosocomial legionellosis cases, colonisation by Legionella in water system) about the hospitals and the LCTFs.
Table 1.
Distribution of Legionella and nosocomial Legionnaires’ disease among Piemonte health care facilities (2004–2009)
| Health care facility code | Case mix | Number of beds | Nosocomial legionellosis cases | Legionella spp | MAb 3/1 |
|---|---|---|---|---|---|
| 1 | 1.62 | 1250 | 34 | Lp1, Lp2-14, L.spp | + |
| 2 | 1.1 | 732 | 3 | Lp1, Lp2-14, L.spp, | + |
| 3 | 1.32 | 559 | 17 | Lp1, Lp2-14, L.spp, | + |
| 4 | 0.81 | 289 | 8 | Lp1, Lp2-14, L.spp, | + |
| 5 | 1.06 | 203 | 9 | Lp1 | + |
| 6 | 1.32 | 368 | 4 | Lp1, L.spp | - |
| 7 | 1.46 | 339 | 1 | Lp1, Lp2-14, L.spp | - |
| 8 | 1.22 | 722 | 1 | Lp1, Lp2-14, Lspp | - |
| 9 | 0.8 | 64 | 0 | Lp1, Lspp | + |
| 10 | 1.41 | 120 | 0 | Lp1, L.spp | - |
| 11 | 0.65 | 92 | 0 | Lp1, L.spp | - |
| 12 | 0.73 | 116 | 0 | Lp1, Lp2-14, L.spp | - |
| 13 | 0.9 | 65 | 0 | Lp1, Lp2-14, Lspp | - |
| 14 | 0.89 | 240 | 0 | Lp1, L.spp | - |
| 15 | 0.48 | 73 | 0 | Lp1, L.spp | - |
| 16 | 0.71 | 111 | 0 | Lp1, Lp2-14, Lspp | - |
| 17 | 0.88 | 255 | 0 | Lp 1 | - |
| 18 | 1.26 | 412 | 0 | Lp1, Lp2-14, Lspp | - |
| 19 | 0.45 | 317 | 0 | Lp1, Lp2-14, Lspp | - |
| 20 | 1.02 | 108 | 0 | Lp1, Lp2-14, Lspp | - |
| 21 | 1.03 | 70 | 0 | Lp1, Lp2-14, Lspp | - |
| 22 | 0.83 | 160 | 1 | Lp2-14 | n.a |
| 23 | 0.77 | 225 | 1 | Lp2-14 | n.a. |
| 24 | 1.12 | 193 | 1 | Lp2-14, L.spp | n.a. |
| 25 | 1.27 | 448 | 1 | Lp2-14 | n.a. |
| 26 | 0.92 | 482 | 2 | Lp2-14, Lspp, | n.a |
| 27 | 0.76 | 196 | 0 | Lp2-14, Lspp, | n.a. |
| 28 | 0.85 | 268 | 0 | Lp2-14, Lspp | n.a. |
| 29 | 0.78 | 57 | 0 | Lp2-14 | n.a |
| 30 | 0.80 | 86 | 0 | Lp2-14, Lspp, | n.a. |
| 31 | 0.81 | 90 | 0 | Lp2-14, Lspp | n.a. |
| 32 | 0.80 | 30 | 0 | Lp2-14, Lspp | n.a |
| 33 | 0.82 | 54 | 0 | Lp2-14, Lspp | n.a. |
| 34 | 0.89 | 228 | 0 | Lp2-14 | n.a. |
| 35 | 1.19 | 138 | 0 | Lp2-14 | n.a |
| 36 | 0.93 | 85 | 0 | Lp2-14 Lspp | n.a. |
| 37 | 0.53 | 175 | 0 | Lp2-14, Lspp | n.a. |
| 38 | 0.90 | 242 | 0 | Lp2-14 | n.a |
| 39 | 0.76 | 72 | 0 | Lp2-14 | n.a. |
| 40 | 0.82 | 85 | 0 | Lp2-14, Lspp | n.a. |
| 41 | 0.48 | 482 | 0 | Lp2-14, Lspp | n.a. |
| 42 | 0.76 | 49 | 0 | Lspp | n.a. |
| 43 | 0.66 | 73 | 0 | Lp2-14 | n.a. |
| 44 | 1.17 | 82 | 0 | Lp2-14, Lspp | n.a |
| 45 | 0.87 | 48 | 0 | Lp3 | n.a. |
| 46 | 0.70 | 139 | 0 | Lp2-14,Lspp | n.a. |
| 47 | / | 110 | 2 | Lp1, Lp2-14, L.spp | + |
| 48 | / | 126 | 1 | Lp1 | + |
| 49 | / | 117 | 1 | Lp1, L.spp | - |
| 50 | / | 174 | 0 | Lp1,Lspp | - |
| 51 | / | 60 | 0 | Lp1 | - |
| 52 | / | 30 | 0 | Lspp | n.a |
| 53 | / | 60 | 0 | Lp2-14 | n.a. |
| 54 | / | 174 | 0 | Lp2-14, Lspp | n.a |
| 55 | / | 60 | 0 | Lp2-14 | n.a. |
| 56 | / | 177 | 0 | Lspp | n.a |
n.a. = not applicable.
Lp1 = L. pneumophila sg 1; Lp2-14 = L. pneumophila sg 2–14; L. spp = L. species non-pneumophila.
Based on the analysis of the strains isolated during environmental monitoring in the study period, the HCFs were classified as 1) facilities contaminated by L. pneumophila sg 1 alone or in association with other Legionella serogroups or species (26/56) or 2) as facilities contaminated by one or more L. pneumophila serogroups (sg 2–14) alone or in association with other Legionella species (30/56).
A total of 87 cases of hospital-acquired legionellosis were reported to the regional surveillance system (SeREMI) during the study period; the notifications originated from 16 of the 56 HCFs monitored (Table 1). Comparing the environmental data with the number of hospital-acquired legionellosis it emerges that 2 HCFs colonised with L. pneumophila sg 1 alone reported 10 cases; 5 HCFs that were not colonised with L. pneumophila sg 1 reported 6 cases, the remaining 9 HCFs colonised with several serogroups (L. pneumophila sg 1 and others serogroups) reported 71 cases.
The association between the type of colonisation (L. pneumophila sg 1 vs others serogroups) and the incidence of reported cases was statistically significant (p = 0.03 according to the χ2 test) (Table 2). Since diagnosis of Legionella infection was made by urinary antigen, linkage between infection and environment can only be hypothesized; in fact in 9 hospitals there was a colonization with several serogroups.
Table 2.
Association between colonisation with L. pneumophila sg 1 and reported cases of legionellosis
| HCFs with reported cases | HCFs without reported cases | Total | |
|---|---|---|---|
| HCFs colonised with L. pneumophila sg 1 and other serogroup and species | 11 | 15 | 26 |
| HCFs colonised with L. pneumophila sg 2–14 and other species | 5 | 25 | 30 |
| Total | 16 | 40 | 56 |
p = 0.03 according to the χ2 test.
Legionella strains with the virulence–associated epitope recognised by MAb 3/1 were isolated in 8 of the 26 HCFs colonised by L. pneumophila sg 1; 7 of the HCFs colonised by MAb 3/1-positive strains accounted for 85% of the cases of hospital-acquired legionellosis reported during the 6-year study period.
Analysis of isolates during the years of the study showed variation of reactivity of MAb 3/1only in Hospital No. 9, where it was also isolated a strain 3/1 MAb negative.
There was a statistically significant association (p = 0.003 according to Fisher’s exact test) between the presence of cases and colonisation by MAb 3/1-positive Legionella strains (Table 3). One HCF (No. 9) had no cases of legionellosis even though it was colonised by MAb 3/1-positive Legionella strains. In contrast, one HCF (No. 6) reported 4 cases even though it was colonised by MAb 3/1-negative Legionella.
Table 3.
Legionellosis cases and colonisation with Legionella MAb 3/1 positive strains
| HCFs with reported cases | HCFs without reported cases | Total | |
|---|---|---|---|
| HCFs colonised with L. pneumophila sg 1 MAb 3/1 positive | 7 | 1 | 8 |
| HCFs colonised with L. pneumophila sg 1 MAb 3/1 negative | 4 | 14 | 18 |
| Total | 11 | 15 | 26 |
p = 0.003 according to Fisher’s exact test.
No statistically significant differences (p = 0.7 according to Fisher’s exact test) were found in the occurrence of legionellosis for the HCFs colonised by MAb 3/1-negative L. pneumophila sg 1 compared with those colonised by L. pneumophila sg 2–14 (Table 4). This result suggests that there is no greater risk of infection HCFs in facilities colonised by L. pneumophila sg 1 without the virulence–associated epitope recognised by MAb 3/1 compared with those colonised by L. pneumophila sg 2–14.
Table 4.
Legionellosis cases in health care facilities colonised with L. pneumophila sg 2–14 and/or L. pneumophila sg 1 MAb 3/1 negative
| HCFs with reported cases | HCFs without reported cases | Total | |
|---|---|---|---|
| HCFs colonised with L. pneumophila sg 1 MAb 3/1 negative | 4 | 14 | 18 |
| HCFs colonised with L. pneumophila sg 2-14 | 5 | 25 | 30 |
| Total | 9 | 39 | 48 |
p = 0.7 according to Fisher’s exact test.
Furthermore, we analysed the 56 HCFs to determine whether the complexity of care (i.e. the case-mix) was also an important factor in the occurrence of legionellosis (Table 5). To this aim we merged the structures colonized by MAb 3/1-negative L. pneumophila sg 1 with those colonized by L. pneumophila sg 2–14. Analysis of the raw data (univariate analysis) showed an association between the presence of MAb and the presence of cases (p = 0.0006 by Fisher exact test). With the layering by a stratifying of the data we found a statistically significant association between colonisation and reported cases only in the HCFs classified as CMI < 1 (p = 0.02 according to Fisher’s exact test).
Table 5.
Association of MAb 3/1, CMI and reported cases
| a) HCF | b) HCF with CMI < 1 | c) HCF with CMI >1 | ||||
|---|---|---|---|---|---|---|
| MAb 3/1 | HCFs without reported cases | HCFs with reported cases | HCFs without reported cases | HCFs with reported cases | HCFs without reported cases | HCFs with reported cases |
| Negative(a) | 39 | 9 | 33 | 4 | 6 | 5 |
| Positive | 1 | 7 | 1 | 3 | 0 | 4 |
| p = 0.0006 | p = 0.02 | p = 0.18 | ||||
| (Fisher’s exact test) | (Fisher’s exact test) | (Fisher’s exact test) | ||||
(a) both the HCF colonized by L. pneumophila. sg 1 MAb 3/1 negative, and all other structures colonized by L. pneumophila sg 2–14.
Discussion
L. pneumophila sg 1 is responsible for the majority of hospital-acquired infections. Some strains of the L. pneumophila sg 1 population have an enhanced ability to cause disease: the clinical predominance of L. pneumophila sg 1 strains with specific genotypes suggests that they have the ability to cause infections in humans [28, 29, 14]. Among the L. pneumophila sg 1 strains, some monoclonal subgroups (Knoxville, Philadelphia, Benidorm, France/Allentown) display the virulence-associated epitope recognised by MAb 3/1; these strains seem to be associated with hospital outbreaks, travel-associated infections or community-acquired infections [26, 10]. There are some published data [10, 13, 14, 30, 31] on the serogroup and monoclonal subgroup distribution of L. pneumophila in man-made water systems that are associated or not associated with human disease. This paper describes the first Italian study in which information about the environmental distribution of strains according to their MAb 3/1 profile has been examined. This distribution was compared with the occurrence of legionellosis.
Our laboratory is involved in the environmental monitoring of many HCFs in Piemonte (area 25,399 km2; population 4,446,230); thus, we collected environmental strains from water systems in HCFs that are representative of the wider L. pneumophila population in our region.
The purpose of this study was to compare the distribution of L. pneumophila sg 1 monoclonal subtypes obtained during routine sampling in 56 man-made HCF water systems with the distribution of hospital-acquired legionellosis, to assess the risk associated with contaminated environmental reservoirs colonised by more virulent strains.
We could acknowledge two methodological limitation of this study: first, owing to this investigation being an ecological study, we didn’t observe the characteristics of the patients involved and we cannot exclude that we could not identify and consider some potential confounding variables; second, since diagnosis of legionellosis in Piemonte is based on urinary antigen detection, it is not possible an epidemiological comparison between clinical and environmental strain to confirm the infection origin.
Of the 56 health care facilities that we monitored, 26 were colonised by L. pneumophila sg 1 alone or in association with other L. pneumophila serogroups. Only 8 (31%) of these facilities were colonised by MAb 3/1-positive L. pneumophila sg 1, indicating that the total frequency of colonisation by MAb 3/1-positive L. pneumophila sg 1 was 14% (8/56) among the HCFs. This observation aligns with the findings of other studies that most environmental isolates are MAb 3/1-negative, in contrast to human isolates [10, 32–34]. The comparison between the environmental data and the data on the cases of Legionnaires’ disease showed that 93% of the cases (81/87) occurred in the HCFs colonised by L. pneumophila sg 1 alone or with others serogroups. Among the L. pneumophila sg 1 strains, the monoclonal subgroup with the virulence-associated epitope recognised by MAb 3/1 was isolated in 27% (7/26) of the hospitals, which had reported 85% (74/87) of the cases (Table 1). Only one health care facility colonised by MAb 3/1-positive L. pneumophila sg 1 (No. 9, Table 1) had no reported cases of legionellosis. From 2004 to 2006 this hospital had two medical wards (64 beds) while from 2005 to 2009 was no longer an hospital but was intended only for hemodialysis center. Moreover in this hospital was highlighted a variation of the reactivity of MAb 3/1 from positive to negative.
Only one health care facility colonised by MAb 3/1-negative L. pneumophila sg 1 (No. 6, Table 1) reported four cases of legionellosis. Despite the epidemological investigation, the infection sources remained unknown. Health authorities hypothesized the involvement of the cooling towers of a supermarket in the nearby of the hospital.
The epidemiological data for Piemonte (Table 1) show that the reporting rates are particularly high at hospitals that admit patients with severe illnesses; therefore, we analysed the relationship between CMI, MAb and hospital-acquired infections in the 56 HCFs. As shown in Table 5, we found a statistically significant relationship between the presence of strains MAb 3/1 positive in the environment and the occurrence of cases of legionellosis. After stratification for CMI, the association was confirmed only for low-complexity hospitals (CMI < 1) while disappeared for high complexity hospitals (CMI > 1). These results might suggest that the subjects with less severe illnesses may need more virulent strains to get sick while patient with severe underlying disease, hospitalised in facilities with CMI > 1, were more susceptible to becoming infected even by less aggressive strains. This observation aligns with the findings of Helbig and colleagues [10], who found that most clinical isolates in hospitals are MAb 3/1-negative.
Conclusions
Our study suggests that MAb 3/1 subtyping of L. pneumophila sg 1 strains may be useful for assessing the risk associated with contaminated environmental reservoirs. Hospitals colonised by more virulent strains should be advised to increase their case monitoring efforts and to implement more effective contamination control strategies. Many of the guidelines and official recommendations for preventing the transmission of Legionnaires’ disease recommend action items based solely on certain concentrations of legionellae or on the number of sites that are positive for the bacteria [35, 36]. None of these guidelines discriminate among the large number of Legionella species or serogroups, even though it is clear that they differ in their capacity to cause disease. Better characterisation of the strains that cause the majority of diseases would allow for more targeted intervention measures.
Our results support the opinion stated by Harrison et al. [14]. That “knowing which particular strain is present in an environment might be at least as important as knowing the quantity in which legionellae are present”.
Acknowledgements
We wish to thank Dr. Maria Vittoria Stefanetti at the Regional Agency for Environmental Protection (ARPA, Novara) for kindly providing some of the Legionella strains, Prof. J. Helbig (Institute of Medical Microbiology and Hygiene, TU Dresden) for providing the MAb 3/1 and Dr. L. Charrier for statistical assistance.
Footnotes
Competing interests
The authors declare that they have no competing interests.
Authors’ contributions
SD designed the study, performed IFT test, data analysis and wrote the manuscript. MG performed the experiments and partecipated in literature search, data analysis, manuscript writing, editing and submission of the manuscript. SRAR carried out culture of water samples and serological typing of legionellae. CMZ partecipated in the study design, analysis and interpretation of the data and critically revised the manuscript RR and PF provided data and information about the cases. All authors read and approved the final manuscript.
Contributor Information
Savina Ditommaso, Email: savina.ditommaso@unito.it.
Monica Giacomuzzi, Email: monica.giacomuzzi@unito.it.
Susan R Arauco Rivera, Email: susan.arauco@unito.it.
Roberto Raso, Email: rraso@aslal.it.
Pierangela Ferrero, Email: pferrero@aslal.it.
Carla M Zotti, Email: carla.zotti@unito.it.
References
- 1.Fields BS, Benson RF, Besser RE. Legionella and Legionnaires’ disease: 25 years of investigation. Clin Microbiol Rev. 2002;15:506–526. doi: 10.1128/CMR.15.3.506-526.2002. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2.Allegheny County Health Department . Approaches to prevention and control of Legionella infection in Allegheny County Health Care Facilities. 2. Pittsburgh PA: Allegheny County Health Department; 1997. [Google Scholar]
- 3.CDC Guidelines for preventing health-care-associated pneumonia. MMWR Morb Mortal Wkly Rep. 2003;53:1–36. [PubMed] [Google Scholar]
- 4.CDC Guidelines for preventing opportunistic infections among hematopoietic stem cell transplant recipients. MMWR Morb Mortal Wkly Rep. 2000;49:1–128. [PubMed] [Google Scholar]
- 5.Ministère de la Santé et des Solidarietès . L’eau dans les établissements de santé - guide technique. Paris: Paris; 2005. [Google Scholar]
- 6.Ditommaso S, Giacomuzzi M, Biasin C, Gentile M, Maggiorotto G, Ruggenini Moiraghi A, Zotti CM, Legionellosis Collaborating Group Incidence of legionellosis in hospitals contaminated by Legionella pneumophila other than serogroup 1. Infect Control Hosp Epidemiol. 2007;28:509–511. doi: 10.1086/513118. [DOI] [PubMed] [Google Scholar]
- 7.Alary MA, Joly JR. Factors contributing to the contamination of hospital water distribution systems by Legionellae. J Infect Dis. 1992;165:565–569. doi: 10.1093/infdis/165.3.565. [DOI] [PubMed] [Google Scholar]
- 8.Marrie TJ, MacDonald S, Clarke K, Haldane D. Nosocomial Legionnaires’ disease: lessons from a four year prospective study. Am J Infect Control. 1991;19:79–85. doi: 10.1016/0196-6553(91)90043-C. [DOI] [PubMed] [Google Scholar]
- 9.Aurell H, Etienne J, Forey F, Reyrolle M, Girardo P, Farge P, Decludt B, Campese C, Vandenesch F, Jarraud S. Legionella pneumophila serogroup 1 strain Paris: endemic distribution throughout France. J Clin Microbiol. 2003;41:3320–3322. doi: 10.1128/JCM.41.7.3320-3322.2003. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10.Helbig JH, Bernander S, Castellani Pastoris M, Etienne J, Gaia V, Lauwers S, Lindsay D, Lück PC, Marques T, Mentula S, Peeters MF, Pelaz C, Struelens M, Uldum SA, Wewalka G, Harrison TG. Pan-European study on culture-proven Legionnaires’ disease: distribution of Legionella pneumophila serogroups and monoclonal subgroups. Eur J Clin Microbiol Infect Dis. 2002;2002(21):710–716. doi: 10.1007/s10096-002-0820-3. [DOI] [PubMed] [Google Scholar]
- 11.Yu VL, Plouffe JF, Pastoris MC, Stout JE, Schousboe M, Widmer A, Summersgill J, File T, Heath CM, Paterson DL, Chereshsky A. Distribution of Legionella species and serogroups isolated by culture in patients with sporadic community-acquired legionellosis: an international collaborative survey. J Infect Dis. 2002;186:127–128. doi: 10.1086/341087. [DOI] [PubMed] [Google Scholar]
- 12.Ricketts K, Joseph C, European Working Group for Legionella Infections Health Protection Agency, CDSC, London, UK Travel associated legionnaires’ disease in Europe: 2002. Euro Surveill. 2004;9:6–9. doi: 10.2807/esm.09.10.00480-en. [DOI] [PubMed] [Google Scholar]
- 13.Doleans A, Aurell H, Reyrolle M, Lina G, Freney J, Vandenesch F, Etienne J, Jarraud S. Clinical and environmental distributions of Legionella strains in France are different. J Clin Microbiol. 2004;42:458–460. doi: 10.1128/JCM.42.1.458-460.2004. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14.Harrison TG, Afshar B, Doshi N, Fry NK, Lee JV. Distribution of Legionella pneumophila serogroups, monoclonal antibody subgroups and DNA sequence types in recent clinical and environmental isolates from England and Wales (2000–2008) Eur J Clin Microbiol Infect Dis. 2009;28:781–791. doi: 10.1007/s10096-009-0705-9. [DOI] [PubMed] [Google Scholar]
- 15.Conferenza permanente per i rapporti tra lo Stato, le Regioni e le province autonome di Trento e Bolzano . Linee guida per la prevenzione e il controllo della legionellosi. 2000. pp. 1–35. [Google Scholar]
- 16.Helbig JH, Lück PC, Knirel YA, Witzleb W, Zähringer U. Molecular characterization of a virulence-associated epitope on the lipopolysaccharide of Legionella pneumophila serogroup 1. Epidemiol Infect. 1995;115:71–78. doi: 10.1017/S0950268800058131. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17.Helbig JH, Kurtz JB, Pastoris MC, Pelaz C, Lück PC. Antigenic lipopolysaccharide components of Legionella pneumophila recognized by monoclonal antibodies: possibilities and limitations for division of the species into serogroups. J Clin Microbiol. 1997;35:2841–2845. doi: 10.1128/jcm.35.11.2841-2845.1997. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18.Dournon E, Bibb WF, Rajagopalan P, Desplaces N, McKinney RM. Monoclonal antibody reactivity as a virulence marker for Legionella pneumophila serogroup 1 strains. J Infect Dis. 1988;157:496–501. doi: 10.1093/infdis/157.3.496. [DOI] [PubMed] [Google Scholar]
- 19.Stout JE, Joly J, Para M, Plouffe JF, Plouffe J, Ciesielski C, Blaser MJ, Yu VL. Comparison of molecular methods for subtyping patients and epidemiologically linked environmental isolates of Legionella pneumophila. J Infect Dis. 1988;157:486–495. doi: 10.1093/infdis/157.3.486. [DOI] [PubMed] [Google Scholar]
- 20.Dennis PJ, Lee JV. Differences in aerosol survival between pathogenic and non-pathogenic strains of Legionella pneumophila serogroup 1. J Appl Bacteriol. 1988;65:135–141. doi: 10.1111/j.1365-2672.1988.tb01501.x. [DOI] [PubMed] [Google Scholar]
- 21.Gosselin F, Duval JF, Simonet J, Ginevra C, Gaboriaud F, Jarraud S, Mathieu L. Impact of the virulence-associated MAb3/1 epitope on the physicochemical surface properties of Legionella pneumophila sg1: An issue to explain infection potential? Colloids Surf B Biointerfaces. 2011;82:283–290. doi: 10.1016/j.colsurfb.2010.08.040. [DOI] [PubMed] [Google Scholar]
- 22.Ditommaso S, Giacomuzzi M, Gentile M, Moiraghi AR, Zotti CM. Effective environmental sampling strategies for monitoring Legionella spp contamination in hot water systems. Am J Infect Control. 2010;38:344–349. doi: 10.1016/j.ajic.2009.09.016. [DOI] [PubMed] [Google Scholar]
- 23.Regione Piemonte . Raccomandazioni per la sorveglianza, la prevenzione e il controllo delle polmoniti da Legionella nelle strutture sanitarie piemontesi pubbliche e private. 2008. [Google Scholar]
- 24.Ditommaso S, Guidetti L, Giacomuzzi M, Vallana M, Ghia C, Pepe N, Maiello A, Zotti C, Vioglio R, Moiraghi Ruggenini A. Contaminazione da Legionella degli impianti idrici degli ospedali piemontesi. View Rev. 2000;1:11–15. [Google Scholar]
- 25.International Standard Organization . Water quality detection and enumeration of Legionella. ISO 11731. Geneva: International Standards Organization; 1998. [Google Scholar]
- 26.Bernander S, Jacobson K, Helbig JH, Lück PC, Lundholm M. A hospital-associated outbreak of Legionnaires’ disease caused by Legionella pneumophila serogroup 1 is characterized by stable genetic fingerprinting but variable monoclonal antibody patterns. J Clin Microbiol. 2003;41:2503–2508. doi: 10.1128/JCM.41.6.2503-2508.2003. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 27.Wilkinson HW. Hospital-laboratory diagnosis of Legionella infections. 1987. [Google Scholar]
- 28.Borchardt J, Helbig JH, Lück PC. Occurrence and distribution of sequence types among Legionella pneumophila strains isolated from patients in Germany: common features and differences to other regions of the world. Eur J Clin Microbiol Infect Dis. 2008;27:29–36. doi: 10.1007/s10096-007-0392-3. [DOI] [PubMed] [Google Scholar]
- 29.Chasqueira MJ, Rodrigues L, Nascimento M, Marques T. Sequence-based and monoclonal antibody typing of Legionella pneumophila isolated from patients in Portugal during 1987–2008. Euro Surveill. 2009;14:1–4. doi: 10.2807/ese.14.28.19271-en. [DOI] [PubMed] [Google Scholar]
- 30.Kozak NA, Benson RF, Brown E, Alexander NT, Taylor TH, Jr, Shelton BG, Fields BS. Distribution of lag-1 alleles and sequence-based types among Legionella pneumophila serogroup 1 clinical and environmental isolates in the United States. J Clin Microbiol. 2009;47:2525–2535. doi: 10.1128/JCM.02410-08. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 31.Amemura-Maekawa J, Kikukawa K, Helbig JH, Kaneko S, Suzuki-Hashimoto A, Furuhata K, Working Group for Legionella in Japan Distribution of monoclonal antibody subgroups and sequence-based types among Legionella pneumophila serogroup 1 isolates derived from cooling tower water, bathwater, and soil in Japan. Appl Environ Microbiol. 2012;2012(78):4263–4270. doi: 10.1128/AEM.06869-11. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 32.Lück PC, Helbig JH. Typing of Legionella strains isolated from patients and environmental sources in Germany, 1990 to 2000. In: Marre R, editor. Legionella. Washington DC: ASM Press; 2002. pp. 267–270. [Google Scholar]
- 33.Pelaz C, García L, Martín-bourgon C. Legionellae isolated from clinical and environmental samples in Spain (1983–90): monoclonal typing of Legionella pneumophila serogroup 1 isolates. Epidemiol Infect. 1992;108:397–402. doi: 10.1017/S0950268800049906. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 34.Pringler N, Brydov P, Uldum SA. Occurrence of. Legionella in Danish hot water systems. In: Marre R, editor. Legionella. Washington DC: ASM Press; 2002. pp. 298–301. [Google Scholar]
- 35.World Health Organization . Legionella and the prevention of legionellosis. 2007: WHO; 2007. [Google Scholar]
- 36.Fields BS, Moore MR. Control of legionellae in the environment: a guide to the US guidelines. ASHRAE Trans. 2006;112:691–699. [Google Scholar]
Pre-publication history
- The pre-publication history for this paper can be accessed here:http://www.biomedcentral.com/1471-2334/14/483/prepub